Pulmonary Vascular
-
New fund empowers CHEST Networks to pursue their most impactful ideas
The Networks Advancement Fund offers financial support for projects that directly advance CHEST’s philanthropic pillars while furthering the mission of an individual Network.
-
Bridging the gap: Mechanical circulatory support in lung transplantation for PAH
Review the need for ECLS, MCS, and ECMO in patients with PAH who are undergoing lung transplantation.
-
2026 GOLD report provides key updates on COPD exacerbations, case finding
Gerard J. Criner, MD, FCCP, a member of the GOLD Science Committee, said the latest insights aim to improve patient outcomes and bring awareness to treating COPD exacerbations.
-
Hypoxic burden emerges as a key cardiovascular risk marker in pediatric OSA
Investigator Olga Mediano, PhD, said hypoxic burden may more fully capture the physiological consequences of OSA by integrating the frequency, duration, and depth of oxygen desaturation events.
-
Data show OSA is an independent, modifiable risk factor for cerebral microbleeds
The first prospective, longitudinal study of OSA and cerebral microbleeds (CMBs) found that moderate to severe OSA more than doubles the risk for microbleeds.
-
Trials suggest RSV vaccine reduces hospitalization for cardiorespiratory conditions in older adults
Data from studies in the United States and Denmark add to the growing evidence that respiratory syncytial virus (RSV) vaccination is effective in older adults.
-
Third trial supports sotatercept to treat PAH
Guidelines expert James R. Klinger, MD, FCCP, said that while the evidence of efficacy is clear, more research is needed to address questions regarding the optimal duration of therapy and the potential for disease progression if therapy is stopped.
-
Experts evaluate treatment of PAH in the sotatercept era
Zeenat Safdar, MD, FCCP, reviewed recent clinical trial data on the use of the activin-signaling inhibitor sotatercept in pulmonary arterial hypertension (PAH).
-
Small steps toward a noninvasive approach to pulmonary hypertension
Noninvasive imaging approaches, particularly echocardiography-based and CT scan-based main pulmonary artery diameter assessment, offer complementary insights into early PH detection and risk stratification.
-
Session to highlight identification and management of right ventricular failure
Jorge Velazco, MD, FCCP, will chair a Wednesday morning session on the basics of right ventricular failure pathophysiology, medical treatment, echocardiographic evaluation, and advanced management with mechanical circulatory support.
-
Session addresses complex pulmonary vascular challenges in cirrhosis
Yu Kuang (Julie) Lai, MD, detailed the diagnosis of hepatopulmonary syndrome and post-liver transplant hypoxemia during the session, which also reviewed portopulmonary hypertension.
-
Session to discuss the management of pulmonary disease during pregnancy
Lisa K. Moores, MD, FCCP, will present during a Tuesday afternoon session on how physiology during pregnancy alters the clinical presentation and management of pulmonary disorders.
